- $2.16bn
- $1.87bn
- $526.50m
- 32
- 24
- 93
- 48
Annual balance sheet for LEMONADE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Prepaid Expenses | |||||
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.7 | 33.6 | 46 | 34.8 | 31.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 829 | 1,511 | 1,691 | 1,633 | 1,849 |
Accounts Payable | |||||
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 288 | 522 | 824 | 924 | 1,256 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 541 | 988 | 867 | 709 | 593 |
Total Liabilities & Shareholders' Equity | 829 | 1,511 | 1,691 | 1,633 | 1,849 |
Total Common Shares Outstanding |